STOCK TITAN

[SCHEDULE 13G/A] InspireMD, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Rosalind Advisors and affiliated funds report shared beneficial ownership in InspireMD (NSPR), including common shares and warrants that together total 10,987,104 securities representing 9.4% of the class as stated on the cover page. The holding is shown as 3,905,743 common shares plus 7,081,361 shares issuable on warrants for the Advisor group, while Rosalind Master Fund L.P. reports 3,508,336 common and 5,977,361 warrant-issuable shares, and Rosalind Opportunities Fund I L.P. reports 397,407 common and 1,104,000 warrant-issuable shares. The filing notes that blocker provisions limit exercise of some warrants, so the actual exercisable ownership is lower than the raw totals. The Advisor and certain principals disclaim beneficial ownership of shares held by advised funds.

Rosalind Advisors e i fondi affiliati dichiarano la proprietà beneficiaria condivisa di InspireMD (NSPR), comprendente azioni ordinarie e warrant che insieme ammontano a 10,987,104 titoli, pari al 9.4% della classe come indicato in copertina. La partecipazione è riportata come 3,905,743 azioni ordinarie più 7,081,361 azioni emesse mediante warrant per il gruppo Advisor, mentre Rosalind Master Fund L.P. segnala 3,508,336 ordinarie e 5,977,361 azioni esercitabili da warrant, e Rosalind Opportunities Fund I L.P. segnala 397,407 ordinarie e 1,104,000 azioni esercitabili da warrant. Il deposito osserva che clausole blocker limitano l'esercizio di alcuni warrant, quindi la posizione effettivamente esercitabile è inferiore ai totali lordi. L'Advisor e taluni dirigenti rinunciano alla proprietà beneficiaria delle azioni detenute dai fondi da loro consigliati.

Rosalind Advisors y fondos afiliados informan de la propiedad beneficiaria compartida en InspireMD (NSPR), incluyendo acciones ordinarias y warrants que suman en conjunto 10,987,104 títulos, lo que representa el 9.4% de la clase según se indica en la portada. La tenencia se muestra como 3,905,743 acciones ordinarias más 7,081,361 acciones emitibles por warrants para el grupo Advisor, mientras que Rosalind Master Fund L.P. reporta 3,508,336 ordinarias y 5,977,361 acciones emitibles por warrants, y Rosalind Opportunities Fund I L.P. reporta 397,407 ordinarias y 1,104,000 acciones emitibles por warrants. La presentación señala que disposiciones blocker limitan el ejercicio de algunos warrants, por lo que la participación realmente ejercitable es menor que los totales brutos. El Advisor y ciertos directivos renuncian a la propiedad beneficiaria de las acciones mantenidas por los fondos que asesoran.

Rosalind Advisors 및 계열 펀드들은 InspireMD (NSPR)에 대한 공동 실질 소유를 보고했습니다. 보통주와 워런트를 포함한 총 보유는 10,987,104주로 표지에 기재된 바와 같이 해당 클래스의 9.4%에 해당합니다. 어드바이저 그룹의 보유는 3,905,743 보통주7,081,361 워런트로 발행 가능한 주식으로 표시되며, Rosalind Master Fund L.P.는 3,508,336 보통주5,977,361 워런트 발행 가능 주식을, Rosalind Opportunities Fund I L.P.는 397,407 보통주1,104,000 워런트 발행 가능 주식을 보고합니다. 제출서류는 일부 워런트의 행사에 대해 blocker 조항이 제한을 두고 있어 실제 행사 가능한 소유 비중은 총계보다 낮다고 명시하고 있습니다. Advisor와 일부 주요 인물들은 자문하는 펀드가 보유한 주식에 대한 실질적 소유권을 부인합니다.

Rosalind Advisors et des fonds affiliés déclarent une propriété bénéficiaire partagée dans InspireMD (NSPR), comprenant des actions ordinaires et des warrants qui totalisent ensemble 10,987,104 titres, représentant 9.4% de la catégorie comme indiqué en page de couverture. La détention est indiquée comme 3,905,743 actions ordinaires plus 7,081,361 actions susceptibles d'être émises à l'exercice de warrants pour le groupe Advisor, tandis que Rosalind Master Fund L.P. déclare 3,508,336 actions ordinaires et 5,977,361 actions émises par warrant, et Rosalind Opportunities Fund I L.P. déclare 397,407 actions ordinaires et 1,104,000 actions émises par warrant. Le dossier note que des dispositions « blocker » limitent l'exercice de certains warrants, de sorte que la possession réellement exerçable est inférieure aux totaux bruts. L'Advisor et certains dirigeants déclinent la propriété bénéficiaire des actions détenues par les fonds qu'ils conseillent.

Rosalind Advisors und verbundene Fonds melden gemeinsames wirtschaftliches Eigentum an InspireMD (NSPR), einschließlich Stammaktien und Warrants, die zusammen 10,987,104 Wertpapiere bzw. 9.4% der Klasse gemäß der Titelseite ausmachen. Die Beteiligung wird für die Advisor-Gruppe mit 3,905,743 Stammaktien plus 7,081,361 durch Warrants auszugebende Aktien angegeben, während Rosalind Master Fund L.P. 3,508,336 Stammaktien und 5,977,361 durch Warrants auszugebende Aktien meldet und Rosalind Opportunities Fund I L.P. 397,407 Stammaktien und 1,104,000 durch Warrants auszugebende Aktien angibt. Die Einreichung weist darauf hin, dass sogenannte Blocker-Bestimmungen die Ausübung mancher Warrants einschränken, sodass das tatsächlich ausübungsfähige Eigentum geringer ist als die Rohsumme. Der Advisor und bestimmte Führungspersonen weisen eine wirtschaftliche Eigentümerschaft an den von den beratenen Fonds gehaltenen Aktien zurück.

Positive
  • Significant institutional interest: Reporting persons disclose a 9.4% economic position, indicating notable investor commitment to NSPR.
  • Clear disclosure of warrant exposure: The filing separates common shares from warrant-issuable shares, improving transparency about potential dilution.
Negative
  • Exercisability limited by blockers: Warrant exercise is restricted to prevent ownership above 9.99%, so reported totals overstate immediate control or voting power.
  • Potential ambiguity in outstanding-share bases: The filing references different outstanding-share counts for percentage calculations, which may cause confusion about exact ownership percentages.

Insights

TL;DR: A passive investor group reports a near-10% economic position in NSPR largely via warrants; blockers limit immediate dilution and voting impact.

The Schedule 13G/A shows Rosalind Advisors and affiliated funds/individuals holding a combined reported position of 10,987,104 securities (3.9M common + 7.08M warrant-issuable). Material here is the split between currently outstanding common shares and shares tied to warrants plus the explicit blocker provisions that prevent exercise beyond ownership thresholds. For investors, this means disclosed economic exposure is significant but immediate voting and control effects are constrained by the blockers and the filing language that indicates passive intent.

TL;DR: Reporting shows substantial stake concentration, but governance influence appears limited by blocker clauses and the Advisor's disclaimer of direct beneficial ownership.

The filing names Rosalind Advisors, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., and two named individuals as reporting persons with shared voting/dispositive power over reported positions. The presence of shared power and the Advisor-client relationships are disclosed, and the Advisor disclaims beneficial ownership of fund holdings. From a governance perspective, the combination of shared power and warrant-based exposure merits monitoring, but the blocker provisions and the 13G-style filing language indicate the group does not currently assert control intent.

Rosalind Advisors e i fondi affiliati dichiarano la proprietà beneficiaria condivisa di InspireMD (NSPR), comprendente azioni ordinarie e warrant che insieme ammontano a 10,987,104 titoli, pari al 9.4% della classe come indicato in copertina. La partecipazione è riportata come 3,905,743 azioni ordinarie più 7,081,361 azioni emesse mediante warrant per il gruppo Advisor, mentre Rosalind Master Fund L.P. segnala 3,508,336 ordinarie e 5,977,361 azioni esercitabili da warrant, e Rosalind Opportunities Fund I L.P. segnala 397,407 ordinarie e 1,104,000 azioni esercitabili da warrant. Il deposito osserva che clausole blocker limitano l'esercizio di alcuni warrant, quindi la posizione effettivamente esercitabile è inferiore ai totali lordi. L'Advisor e taluni dirigenti rinunciano alla proprietà beneficiaria delle azioni detenute dai fondi da loro consigliati.

Rosalind Advisors y fondos afiliados informan de la propiedad beneficiaria compartida en InspireMD (NSPR), incluyendo acciones ordinarias y warrants que suman en conjunto 10,987,104 títulos, lo que representa el 9.4% de la clase según se indica en la portada. La tenencia se muestra como 3,905,743 acciones ordinarias más 7,081,361 acciones emitibles por warrants para el grupo Advisor, mientras que Rosalind Master Fund L.P. reporta 3,508,336 ordinarias y 5,977,361 acciones emitibles por warrants, y Rosalind Opportunities Fund I L.P. reporta 397,407 ordinarias y 1,104,000 acciones emitibles por warrants. La presentación señala que disposiciones blocker limitan el ejercicio de algunos warrants, por lo que la participación realmente ejercitable es menor que los totales brutos. El Advisor y ciertos directivos renuncian a la propiedad beneficiaria de las acciones mantenidas por los fondos que asesoran.

Rosalind Advisors 및 계열 펀드들은 InspireMD (NSPR)에 대한 공동 실질 소유를 보고했습니다. 보통주와 워런트를 포함한 총 보유는 10,987,104주로 표지에 기재된 바와 같이 해당 클래스의 9.4%에 해당합니다. 어드바이저 그룹의 보유는 3,905,743 보통주7,081,361 워런트로 발행 가능한 주식으로 표시되며, Rosalind Master Fund L.P.는 3,508,336 보통주5,977,361 워런트 발행 가능 주식을, Rosalind Opportunities Fund I L.P.는 397,407 보통주1,104,000 워런트 발행 가능 주식을 보고합니다. 제출서류는 일부 워런트의 행사에 대해 blocker 조항이 제한을 두고 있어 실제 행사 가능한 소유 비중은 총계보다 낮다고 명시하고 있습니다. Advisor와 일부 주요 인물들은 자문하는 펀드가 보유한 주식에 대한 실질적 소유권을 부인합니다.

Rosalind Advisors et des fonds affiliés déclarent une propriété bénéficiaire partagée dans InspireMD (NSPR), comprenant des actions ordinaires et des warrants qui totalisent ensemble 10,987,104 titres, représentant 9.4% de la catégorie comme indiqué en page de couverture. La détention est indiquée comme 3,905,743 actions ordinaires plus 7,081,361 actions susceptibles d'être émises à l'exercice de warrants pour le groupe Advisor, tandis que Rosalind Master Fund L.P. déclare 3,508,336 actions ordinaires et 5,977,361 actions émises par warrant, et Rosalind Opportunities Fund I L.P. déclare 397,407 actions ordinaires et 1,104,000 actions émises par warrant. Le dossier note que des dispositions « blocker » limitent l'exercice de certains warrants, de sorte que la possession réellement exerçable est inférieure aux totaux bruts. L'Advisor et certains dirigeants déclinent la propriété bénéficiaire des actions détenues par les fonds qu'ils conseillent.

Rosalind Advisors und verbundene Fonds melden gemeinsames wirtschaftliches Eigentum an InspireMD (NSPR), einschließlich Stammaktien und Warrants, die zusammen 10,987,104 Wertpapiere bzw. 9.4% der Klasse gemäß der Titelseite ausmachen. Die Beteiligung wird für die Advisor-Gruppe mit 3,905,743 Stammaktien plus 7,081,361 durch Warrants auszugebende Aktien angegeben, während Rosalind Master Fund L.P. 3,508,336 Stammaktien und 5,977,361 durch Warrants auszugebende Aktien meldet und Rosalind Opportunities Fund I L.P. 397,407 Stammaktien und 1,104,000 durch Warrants auszugebende Aktien angibt. Die Einreichung weist darauf hin, dass sogenannte Blocker-Bestimmungen die Ausübung mancher Warrants einschränken, sodass das tatsächlich ausübungsfähige Eigentum geringer ist als die Rohsumme. Der Advisor und bestimmte Führungspersonen weisen eine wirtschaftliche Eigentümerschaft an den von den beratenen Fonds gehaltenen Aktien zurück.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 41,720,662 shares of common stock outstanding of the Issuer as of August 1, 2025, in accordance with the S-3 filed on August 1st. However, as more fully described in Item 4, the securities reported in rows 6, 8, and 9 show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8, and 9. (6) 3,905,743 shares of Common Stock 7,081,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)3,905,743 shares of Common Stock 7,081,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)3,905,743 shares of Common Stock 7,081,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)3,508,336 shares of Common Stock 5,977,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)397,407 shares of Common Stock 1,104,000 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:08/11/2025
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:08/11/2025
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:08/11/2025
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:08/11/2025
Rosalind Opportunities Fund I L.P.
Signature:Steven Salamon
Name/Title:Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I)
Date:08/11/2025

FAQ

What stake does Rosalind Advisors report in InspireMD (NSPR)?

Rosalind Advisors and affiliated reporting persons disclose an aggregate of 10,987,104 securities representing 9.4% of the class as stated on the cover page.

How many common shares and warrants are included in the reported position?

The group reports 3,905,743 common shares plus 7,081,361 shares issuable upon exercise of warrants for the Advisor group (other funds have similar breakdowns).

Do the warrants give the holder immediate voting power?

No. The filing discloses blocker provisions that prevent exercise to the extent doing so would push beneficial ownership above certain thresholds, limiting immediate voting impact.

Which entities and individuals are named as reporting persons?

The filing lists Rosalind Advisors, Inc., Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., and individuals Steven Salamon and Gilad Aharon as reporting persons.

Does the Advisor claim direct beneficial ownership of fund holdings?

The Advisor and Mr. Salamon state they disclaim beneficial ownership of the shares held by the advised funds.
Inspiremd

NASDAQ:NSPR

NSPR Rankings

NSPR Latest News

NSPR Latest SEC Filings

NSPR Stock Data

100.96M
19.27M
27.99%
39.21%
1.23%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MIAMI